Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Modelling the evolution of drug resistance in the presence of antiviral drugs.

Modelling the evolution of drug resistance in the presence of antiviral drugs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Modelling the evolution of drug resistance in the presence of antiviral drugs. Abstract Text:

    jianhong wuJianhong Wu,ping yanPing Yan,chris archibaldChris Archibald,jianhong wuJianhong Wu,ping yanPing Yan,chris archibaldChris Archibald,jianhong wuJianhong Wu,ping yanPing Yan,chris archibaldChris Archibald,

    BACKGROUND: The emergence of drug resistance in treated populations and the transmission of drug resistant strains to newly infected individuals are important public health concerns in the prevention and control of infectious diseases such as HIV and influenza. Mathematical modelling may help guide the design of treatment programs and also may help us better understand the potential benefits and limitations of prevention strategies. METHODS: To explore further the potential synergies between modelling of drug resistance in HIV and in pandemic influenza, the Public Health Agency of Canada and the Mathematics for Information Technology and Complex Systems brought together selected scientists and public health experts for a workshop in Ottawa in January 2007, to discuss the emergence and transmission of HIV antiviral drug resistance, to report on progress in the use of mathematical models to study the emergence and spread of drug resistant influenza viral strains, and to recommend future research priorities. RESULTS: General lectures and round-table discussions were organized around the issues on HIV drug resistance at the population level, HIV drug resistance in Western Canada, HIV drug resistance at the host level (with focus on optimal treatment strategies), and drug resistance for pandemic influenza planning. CONCLUSION: Some of the issues related to drug resistance in HIV and pandemic influenza can possibly be addressed using existing mathematical models, with a special focus on linking the existing models to the data obtained through the Canadian HIV Strain and DR Surveillance Program. Preliminary statistical analysis of these data carried out at PHAC, together with the general model framework developed by Dr. Blower and her collaborators, should provide further insights into the mechanisms behind the observed trends and thus could help with the prediction and analysis of future trends in the aforementioned items. Remarkable similarity between dynamic, compartmental models for the evolution of wild and drug resistance strains of both HIV and pandemic influenza may provide sufficient common ground to create synergies between modellers working in these two areas. One of the key contributions of mathematical modeling to the control of infectious diseases is the quantification and design of optimal strategies, combining techniques of operations research with dynamic modeling would enhance the contribution of mathematical modeling to the prevention and control of infectious diseases.

    Modelling the evolution of drug resistance in the presence of antiviral drugs. Publishing Authors By Initials

    j wuJ Wu,p yanP Yan,c archibaldC Archibald,j wuJ Wu,p yanP Yan,c archibaldC Archibald,j wuJ Wu,p yanP Yan,c archibaldC Archibald,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Modelling the evolution of drug resistance in the presence of antiviral drugs. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: BMC public health

    VOLUME: 7

    Page Numbers: 300

    Journal Abbreviation:

    ISSN: 1471-2458

    DAY: 23

    MONTH: 10

    YEAR: 2007

    Modelling the evolution of drug resistance in the presence of antiviral drugs. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100968562

    Modelling the evolution of drug resistance in the presence of antiviral drugs. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Modelling the evolution of drug resistance in the presence of antiviral drugs. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Modelling the evolution of drug resistance in the presence of antiviral drugs.

    AFFILIATION: Center for Disease Modeling, Department of Mathematics and Statistics, York University, 4700 Keele Street, Toronto, M3J 1P3, Canada. wujh@yorku.ca

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: BMC Public Health

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Modelling the evolution of drug resistance in the presence of antiviral drugs Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News